Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Midface Lipofilling
NCT01461785Phase 3Completed
- Sponsor
- Bergman Clinics
- Start
- Apr 2012
- Primary completion
- Jan 2015
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous platelet-rich plasma in facial volume loss (2 arms), sponsored by Bergman Clinics. Primary endpoint: Cutometry at 1 year. Started Apr 2012; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
facial volume loss
Beyond the preview
Go deeper on NCT01461785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461785.